[Transport of cytostatic agents by the plasma proteins. 3. In vitro antitumor action of cytostatic-azoprotein conjugates].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use*; D001798:Blood Proteins; D005340:Fibrinogen; D006834:Hydrazines / Q000627:therapeutic use; D066298:In Vitro Techniques; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012709:Serum Albumin
D000970:Antineoplastic Agents; D001391:Azo Compounds; D001798:Blood Proteins; D006834:Hydrazines; D012709:Serum Albumin; D005340:Fibrinogen; D008727:Methotrexate
Transport d'agents cytostatiques par les protéines plasmatiques. 3. Activité antitumorale in vitro de conjugués cytostatique-azoprotéines.